More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients
Description
CONCLUSION: These findings could suggest an interest in evaluating type 1 IFN treatment in patients with severe COVID-19 and type 1 IFN decline, eventually combined with anti-inflammatory drugs.